Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448851 · ClinicalTrials.gov registry record · Phase 1
Study of Dust Mite Inhalation in Humans
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00448851 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 13 participants.
The verdict
NCT00448851, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about the effect of inhaled dust mite allergen extract on airway responses in allergic individuals with mild asthma. Information learned from this study will be used to identify a safe dose range of D Farinae extract for use in inhalation challenge studies. This study will also help determine how inhalation of the allergen affects mucociliary clearance (MCC) which is a measure of how quickly mucus clears from the airway.
Interventions
- BIOLOGICAL inhaled allergen challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00448851
The ClinicalTrials.gov registry entry for NCT00448851 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which inhaled allergen challenge is the first listed.
NCT00448851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00448851 about?
NCT00448851 is a clinical study titled "Study of Dust Mite Inhalation in Humans". The purpose of this research study is to learn more about the effect of inhaled dust mite allergen extract on airway responses in allergic individuals with mild asthma. Information learned from this study will be used to identify a safe dose range of D Farinae extract for use in inhalation challenge...
What is the current status of trial NCT00448851?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2007-02. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00448851?
The interventions under investigation include: inhaled allergen challenge (BIOLOGICAL).
Who is sponsoring clinical trial NCT00448851?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.